View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Felix Fischer ... (+5)
  • Felix Fischer
  • Jayanth Kandalam
  • Peter Low
  • Si Yong Ng
  • Tanvi Arora

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: Assemblin, Boels, Techem, Pfleiderer, Maxeda, Hapag-Lloyd, Best Secret (Schustermann & Borenstein), Bombardier, TUI, Air France-KLM, Rekeep

Felix Fischer ... (+6)
  • Felix Fischer
  • Haidje Rustau
  • Jayanth Kandalam
  • Peter Low
  • Si Yong Ng
  • Tanvi Arora

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: Techem, Aggreko, Trivium, Novelis, Virgin Media O2, MasOrange, Salt, Assemblin, Aston Martin, Maxeda, Crown Holdings, Polynt, TUI, Hapag-Lloyd

Oscar Haffen Lamm
  • Oscar Haffen Lamm

Medincell: Uzedy TRx shows strong demand, mdc-TJK NDA filing expected ...

Yesterday Teva presented its Q1'25 results, with Uzedy sales for the quarter coming in at USD39m (+160% YoY). While beating Teva's css (USD32.5m, +20%), sales appeared relatively flattish compared Q4 (USD43m), which could be attributed to calendar effects and stock adjustments. We remain optimistic

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Loic Morvan
  • Loic Morvan

Interparfums: sweet scent of Q1 sales

Interparfums has reported 10.7% sales growth for Q1 (+8% at same FX). The fragrance market remained strong, including in the US. Since the beginning of April, momentum has been less dynamic and more volatile. Nevertheless, the group's management reiterated FY sales guidance (EUR930m to EUR935m). We

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Oscar Haffen Lamm
  • Oscar Haffen Lamm

MedinCell and iM4TB to initiate development of a Macozinone LAI in tub...

MedinCell and iM4TB to initiate the development of a LAI version of Macozinone for the treatment of tuberculosis, a potential first-in-class which has shown promising results in past phase 1/2 studies. The value add of a long-acting formulation in tuberculosis is clear, considering that current tre

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet

TUI AG: 1 director

A director at TUI AG bought 4,000 shares at 6.070EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

Oscar Haffen Lamm
  • Oscar Haffen Lamm

MedinCell: patient and HCP survey highlight key features of its olanza...

Teva presented early clinical feedback from a patient and healthcare professional survey regarding its olanzapine LAI TEV'749 (mdc-TJK), in particular around important schizophrenia treatment factors — dosing schedule, initiation regimen, SC administration, post-injection monitoring requirements an

Felix Fischer ... (+5)
  • Felix Fischer
  • Jayanth Kandalam
  • Si Yong Ng
  • Tanvi Arora
  • Trung Nguyen

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: Aston Martin, Softbank Group, Recordati, Arxada, Opella, TUI

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch